Viral suppression (VS) in patients newly diagnosed with HIV is critical to reducing morbidity, mortality, and new transmissions. Rapid initiation of antiretroviral therapy (ART) is a promising model to improve VS, but patients must be seen expeditiously by a prescribing provider. Our retrospective study compared patients achieving VS after introduction of medical visits on the same day as HIV diagnoses from 2014 to 2017. The time to VS was evaluated using survival analysis. Wilcoxon two-sample tests evaluated median times to VS (after diagnosis and ART receipt). When 2016–2017 was compared with 2014–2015, a higher proportion of patients achieved VS (96% and 90%, respectively; p = .0292); the median time to VS decreased to 88 from 101 days after diagnosis and to 44 from 70 days after receipt of ART. As clinicians consider rapid ART initiation, a medical visit on the same day as HIV diagnosis is an intermediate intervention that may improve VS.
Debbie Y. Mohammed, DrPH, MS, is an Assistant Professor, Department of Nursing, College of Science and Health, William Paterson University, Wayne, New Jersey, USA, and is a Nurse Practitioner, Saint Michael's Medical Center, Newark, New Jersey, USA. Eugene Martin, PhD, is a Professor, Department of Pathology and Laboratory Medicine, Rutgers University, Robert W. Johnson Medical School, Somerset, New Jersey, USA. Russell Brewer, DrPH, is an Associate Professor, Department of Medicine, University of Chicago, Chicago, Illinois, USA. Jihad Slim, MD, is Chair, Division of Infectious Disease, Department of Medicine, Saint Michael's Medical Center, Newark, New Jersey, USA.
Corresponding author: Debbie Y. Mohammed, e-mail: firstname.lastname@example.org
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.